CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or Both.

Abstract excerpt

Inhibitors of cholesteryl ester transfer protein (CETP) were developed due to their ability to raise HDL-C levels. Preclinical studies demonstrated favorable effects on atherosclerotic plaque with CETP inhibitory approaches in animal models. While these agents raise HDL-C and lower LDL-C, most have not proven to reduce cardiovascular event rates in large outcome trials. The state of opinion after all of these...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiovascular Diseases
• Share to Cholesterol Ester Transfer Proteins
• Share to Cholesterol, HDL